PetMed Express, Inc. (PETS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PETS Revenue Growth
PETS Revenue Analysis (2014–2025)
As of May 8, 2026, PetMed Express, Inc. (PETS) generated trailing twelve-month (TTM) revenue of $195.0 million, reflecting significant decline in growth of -25.5% year-over-year. The most recent quarter (Q2 2026) recorded $44.4 million in revenue, down 13.3% sequentially.
Looking at the longer-term picture, PETS's 5-year compound annual growth rate (CAGR) stands at -4.4%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $303.6 million in 2021.
When compared to Healthcare sector peers including CHWY (+9.0% YoY), WOOF (-2.5% YoY), and FRPT (+12.0% YoY), PETS has underperformed the peer group in terms of revenue growth. Compare PETS vs CHWY →
PETS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PETSCurrent | $195M | -25.5% | -4.4% | -0.7% | |
 CHWY | $11.9B | +9.0% | +19.6% | 0.9% | |
 WOOF | $6.0B | -2.5% | +3.9% | 2.0% | |
 FRPT | $1.1B | +12.0% | +28.2% | 8.6% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% |
PETS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $227.0M | -17.2% | $69.1M | 30.5% | $-1,530,000 | -0.7% |
| 2024 | $274.1M | +6.8% | $77.7M | 28.4% | $-6,962,000 | -2.5% |
| 2023 | $256.6M | -6.2% | $71.0M | 27.7% | $6.6M | 2.6% |
| 2022 | $273.4M | -9.9% | $75.3M | 27.6% | $25.7M | 9.4% |
| 2021 | $303.6M | +6.8% | $84.3M | 27.8% | $30.5M | 10.1% |
| 2020 | $284.1M | +0.2% | $81.2M | 28.6% | $31.0M | 10.9% |
| 2019 | $283.4M | +3.5% | $95.3M | 33.6% | $46.2M | 16.3% |
| 2018 | $273.8M | +9.9% | $97.8M | 35.7% | $52.1M | 19.0% |
| 2017 | $249.2M | +6.2% | $79.3M | 31.8% | $37.5M | 15.0% |
| 2016 | $234.7M | +2.3% | $76.3M | 32.5% | $32.4M | 13.8% |
See PETS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PETS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PETS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPETS — Frequently Asked Questions
Quick answers to the most common questions about buying PETS stock.
Is PETS's revenue growth accelerating or slowing?
PETS revenue declined -25.5% year-over-year, contrasting with the 5-year CAGR of -4.4%. TTM revenue fell to $195M. This reverses the prior growth trend.
What is PETS's long-term revenue growth rate?
PetMed Express, Inc.'s 5-year revenue CAGR of -4.4% reflects the variable expansion pattern. Current YoY growth of -25.5% is below this long-term average.
How is PETS's revenue distributed by segment?
PETS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.